期刊文献+

卵泡期长效长方案促排卵患者获得最佳卵巢反应的相关因素分析及预测模型建立

Analysis of relative factors and prediction model for optimal ovarian response in patients with follicular phase long-acting long protocol
原文传递
导出
摘要 目的探索行辅助生殖技术卵泡期长效长方案超促排卵治疗的患者获取最佳卵巢反应的相关指标, 并建立卵巢反应性的诺曼预测模型。方法本研究为回顾性队列研究, 分析2018年7月1日至2019年7月30日期间于福建省妇幼保健院生殖医学中心接受辅助生殖助孕治疗的1289例患者临床资料, 按照获卵数分为卵巢低反应组(获卵数≤5枚)164例, 卵巢正常反应组(5枚<获卵数≤18枚)891例, 卵巢高反应组(获卵数>18枚)234例。通过logistic回归筛选影响卵巢反应性的独立因素, 即为模型入组变量, 并依据模型中的回归系数建立诺曼预测模型。结果三组患者的年龄、抗苗勒管激素(anti-Müllerian hormone, AMH)水平、基础窦卵泡计数(antral follicle count, AFC)差异均有统计学意义[(32.43±3.99)岁, (31.48±3.89)岁, (29.91±3.73)岁;(2.53±1.90)μg/L, (3.79±2.20)μg/L, (5.94±3.12)μg/L;10.24±3.10, 14.50±3.29, 19.81±3.44;均P<0.001]。而体质量指数(body mass index, BMI)、不孕年限及输卵管性不孕原因的差异均无统计学意义(均P>0.05)。三组患者行促排卵的促性腺激素(gonadotropin, Gn)起始剂量差异有统计学意义[(182.62±53.96)U、(166.79±48.20)U、(159.13±43.92)U, P<0.001], Gn使用时间及临床妊娠率差异均无统计学意义(均P>0.05)。多因素逐步回归分析显示, 女方年龄[0.93(0.90~0.96), P=0.007]、AFC[1.07(1.03~1.09), P=0.001]、AMH[1.29(1.20~1.39), P=0.001]、基础卵泡刺激素[0.79(0.73~0.86), P=0.001]、黄体生成素[1.11(1.06~1.23), P=0.010]、Gn起始剂量[1.00(1.00~1.01), P=0.003]、Gn使用总量[1.00(0.99~1.00), P=0.001], 是否为子宫内膜异位症[0.63(0.47~0.86), P=0.001]和多囊卵巢综合征[0.30(0.22~0.91), P=0.030]是超促排卵过程中发生卵巢不同反应的独立因素。根据上述因素构建卵巢反应性的预测模型, 预测卵巢最佳反应状态的准确性为95%。用2019年8月1日至2019年10月30日期间该中心的306例同类患者数据对上述模型进行验证, 共279例患者的预测卵巢反应(获卵数)与实际相符, 符合度为91.2%。模型的一致性指数是0.71。结论筛选出行卵泡期长效长方案超促排卵中影响卵巢反应性的相关因素, 成功建立的诺曼模型能够有效、直观、可视化地预测超促排卵中的卵巢反应性。 Objective To explore the relative factors for best ovarian response in patients undergoing assisted reproductive technology with follicular phase long-acting long protocol,and to establish a Nomogram prediction model of ovarian response.Methods This retrospective cohort study analyzed the clinical data of 1289 patients who received assisted reproductive treatment in the Center for Reproductive Medicine of Fujian Maternity and Child Health Hospital from July 1,2018 to July 30,2019.According to the number of oocytes retrieved,there were 164 cases in the low ovarian response group(≤5 oocytes retrieved),891 cases in the normal ovarian response group(the number of retrieved oocytes was>5,and≤18),and 234 cases in the high ovarian response group(>18 oocytes retrieved).Independent factors affecting ovarian reactivity were screened by logistic regression,which were the model entry variables,and a Nomogram prediction model was established based on the regression coefficients in the model.Results There were statistically significant differences in age,anti-Müllerian hormone(AMH)level and antral follicle count(AFC)among the three groups[32.43±3.99,31.48±3.89,29.91±3.73;(2.53±1.90)μg/L,(3.79±2.20)μg/L,(5.94±3.12)μg/L;10.24±3.10,14.50±3.29,19.81±3.44;all P<0.001].There were no significant differences in body mass index(BMI),duration of infertility and causes of tubal infertility(all P>0.05).The initial dosage of gonadotropin(Gn)used for ovarian hyperstimulation among the three groups was statistically different[(182.62±53.96)U,(166.79±48.20)U,(159.13±43.92)U,P<0.001],while the duration of Gn used and clinical pregnancy rate had no significant differences(all P>0.05).Multifactorial stepwise aggression analysis showed that female age[0.93(0.90-0.96),P=0.007],AFC[1.07(1.03-1.09),P=0.001],AMH[1.29(1.20-1.39),P=0.001],basal follicle-stimulating hormone[0.79(0.73-0.86),P=0.001],luteinizing hormone value[1.11(1.06-1.23),P=0.010],initial dosage of Gn used[1.00(1.00-1.01),P=0.003],total dosage of Gn usd[1.00(0.99-1.00),P=0.001]and the presence or absence of diagnosis of endometriosis[0.63(0.47-0.86),P=0.001]and polycystic ovary syndrome[0.30(0.22-0.91),P=0.030]were independent factors for the occurrence of different ovarian responses during ovarian hyperstimulation.The prediction model of ovarian reactivity was constructed based on the above factors,and the accuracy of predicting the optimal ovarian response state was 95%.The above model was verified with 306 patients'data from August 1,2019 to October 30,2019 in this center,and the predicted ovarian response(number of oocytes obtained)of a total of 279 patients was consistent with the actual situation,with a coincidence degree of 91.2%.The consistency index of the model was 0.71.Conclusion We screened out the relevant factors affecting ovarian response in patients undergoing assisted reproductive technology with follicular phase long-acting long protocol,and established a Nomogram prediction model of ovarian response,which could effectively,intuitively and visually predict ovarian reactivity in hyperstimulation.
作者 姜雯雯 廖秀花 陈晓菁 朱素芹 李榕珊 张华乐 郑备红 Jiang Wenwen;Liao Xiuhua;Chen Xiaojing;Zhu Suqin;Li Rongshan;Zhang Huale;Zheng Beihong(Center for Reproductive Medicine,Fujian Maternity and Child Health Hospital,Affiliated Hospital of Fujian Medical University,Fuzhou 350001,China;Obstetrics and Gynecology Department,Fujian Maternity and Child Health Hospital,Affiliated Hospital of Fujian Medical University,Fuzhou 350001,China)
出处 《中华生殖与避孕杂志》 CSCD 北大核心 2022年第4期338-344,共7页 Chinese Journal of Reproduction and Contraception
基金 国家重点研发计划基金(2018YFC1002105) 福建省卫生健康科研人才培养项目(2019-2-9) 闽财指([2019]827号)。
关键词 卵泡期长效长方案 卵巢反应性 诺曼模型 Follicular phase long-acting long protocol Ovarian response Nomogram prediction model
  • 相关文献

参考文献5

二级参考文献32

  • 1章小维,郭明彩,杨慧霞.高龄初产对妊娠结局的影响[J].中国实用妇科与产科杂志,2005,21(2):111-112. 被引量:161
  • 2Seidman JD, Kjerulff KH. Pathologic findings from the maryland women's health study: practice patterns in the diagnosis of adenomyosis. Int J Gynecol Pathol, 1996, 15 (3):217-21.
  • 3Devlieger R, D'Hooghe T, Timmerman D. Uterine adenomyosis in the infertility clinic. Hum Reprod Update, 2003, 19(2):139-47.
  • 4~ Matalliotakis IM, Katsikis IK, Panidis DK. Adenomyosis: what is the impact on fertility? Curr Opin Obstet Gynecol, 2005, 17(2):261-4.
  • 5Uduwela AS, Perera MAD, Aiqing L, et al. Endometrialmyometrial interface: relationship to adenomyosis and changes in pregnancy. Obstet Gynecol Survey, 2000, 55 (6):390-400.
  • 6Levgur M, Abadi MA, Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol,2000, 95(5):688-91.
  • 7Ota H, Igarashi S, Hatazawa J, et al. Is adenomyosis an immune disease? Hum Reprod Update, 1998, 4(4):360-7.
  • 8de Souza NM, Brosens JJ, Schwieso JE, et al. The potential value of magnetic resonance imaging in infertility. Clin Radiol, 1995, 50(2):75-9.
  • 9Reinhold C, Tafazoli F, Mehio A, et al. Uterine adenomyosis: endovaginal US and MR imaging features with histopathologic correlation. Radiographics, 1999, 19 (Spec):S147-60.
  • 10Kennedy S, Bergqvist A, Chapron C, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod, 2005, 20(10):2698-704.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部